Accugenix® Microbial and Identification and Strain Typing

Comprehensive contract microbial testing is conducted at our FDA-registered, cGMP-compliant laboratories. We have supported QC testing for over 1,000 global facilities within the biopharmaceutical, medical device and nutraceutical industries with our bacterial/fungal identification and strain typing services. Our proprietary solutions have a 98% accurate identification rate with a 99% on-time same-day delivery, reducing production recovery times from investigations and minimizing impact to supply chain cycles.

• AccuGENX-ID®: Genotypic method based on reference method used by taxonomists; samples can be viable or nonviable cultures or simply genomic DNA from your microbial contaminant
• AccuPRO-ID®: Proteotypic method based on MALDI-TOF mass spectrometry technology; provides bacterial identification to the species level with greater accuracy than antiquated biochemical methods; backed up with our genotypic method at no additional cost; a high-value/low-cost solution for routine bacterial identification
• AccuGENX-ST™: Highly accurate sequence-based strain typing method by single or multilocus sequence typing (SLST or MLST); includes custom DNA sequencing of targets outside of standard regions to resolve differences and/or similarities at the strain level
• Axcess™ System: Pairs the Bruker MALDI Biotyper instrument with the industry-leading Accugenix® proprietary microbial libraries through a secure online network
• Tracking & Trending: Complimentary IT solution available through our Accugenix® Customer Portal that generates customizable reports of trends by genus and species, reportable rate of your IDs and compliance with 21 CRF Part 11